Navigation Links
Pacemaker tune-up works chemical wonders on damaged hearts in dogs
Date:3/5/2008

lls from dying, an enzyme called phospho-BCL2 antagonist of cell death, or pBAD for short, which was found to be five times more active in the pacemaker-treated group than in the untreated group.

A second protein, p38 MAP kinase, known to stimulate fibrosis and cell death, was twice as active in late-contracting parts of failing hearts in untreated dogs, than in the same heart zone of dogs who underwent pacemaker resynchronization therapy.

Other proteins that lead to heart cell death and worsen contraction were overexpressed in dogs with untreated heart failure, but not in the pacemaker-treated group. These included calcium-calmodulin-dependent kinase (CaMKII), which is linked to arrhythmia, and tumor necrosis factor-alpha (TNF), which is also tied to damaging inflammation and cell death.

The enzyme Akt, a promoter of cell survival when turned on, was markedly less active in the group whose hearts continued to beat out of sync.

Researchers next plan to look at how pacemakers stimulate biological changes in the heart, with the aim of developing treatments that bring the heart back to a normal, healthy state.

In cardiac resynchronization therapy, both major pumping chambers, known as the right and left ventricles, are stimulated at the same time with a biventricular pacemaker to optimize the muscles beat so that one side does not beat a short time before the other.

The American Heart Association estimates that more than 5 million Americans have some form of congestive heart failure, marked by symptoms such as shortness of breath and fatigue.


'/>"/>

Contact: David March
dmarch1@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Drug, Pacemaker Fight Irregular Heartbeat
2. IPods Dont Interfere With Heart Pacemakers
3. The Leukemia & Lymphoma Society Hosts Workshop On Weighing Treatment Options For Chronic Myelogenous Leukemia
4. Taxol bristle ball: a wrench in the works for cancer
5. Cancer control in Europe works; now it is time to extend it to poorer countries
6. SecureWorks Ranked 6th in Deloittes Technology Fast 50 Program for Georgia
7. AK Steel Reaches VEBA Health Care Settlement With Middletown Works Retirees
8. IOM workshop on less confusing drug labeling, Oct. 12
9. CIDM Collaborates With World Congress to Advance Dialog on Online Provider Networks at WHIT 3.0
10. Crittenton Hospital Medical Center to Participate in United Physicians myWorkspace(R) Initiative
11. MIT works toward novel therapeutic device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... exclusively to healthcare providers, has been retained to lead a national chief ... the top executive search firms in the healthcare industry, B. E. Smith has ...
(Date:9/3/2015)... ... September 03, 2015 , ... Global Vision , the world leader ... spotlighting its award-winning print and artwork inspection solutions, ScanProof and ArtProof at ... at the Olympia London, booth #F33 , Be the first to get a sneak ...
(Date:9/3/2015)... ... September 03, 2015 , ... DiabetesSisters Welcomes ... to announce the additional of Carol Wysham, MD, to their esteemed Board of ... Karczmarczyk, Donna Rice, David Warren, Matt Stella, Tricia Cedotal, Andrea Thomas, Wanda Nicholson ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ProScrub is a ... back & forth, flicker, repeat, and custom speed effects without the use of keyframes. ... speed of effect. ProScrub tools are perfect complements to energetic video productions. ...
(Date:9/3/2015)... ... ... AvePoint, the established leader in enabling enterprise collaboration across platforms ... AvePoint’s solution for facilitating two-way collaboration and external sharing without ever having to leave ... the fifth consecutive year an AvePoint product has made the list. , The panel, ...
Breaking Medicine News(10 mins):Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 4
... NORFOLK, Va., Jan. 7 ValueOptions(R), Inc., the ... today that it has entered into an agreement ... solutions as part of its core product offerings. ... terms of the contract, CareIntegra and ValueOptions(R) will ...
... Kendle (Nasdaq: KNDL ) a,leading, global full-service ... CEO, will participate in the 27th Annual,J.P. Morgan Healthcare ... at,4:30 p.m. Pacific Standard Time. , ... The public is invited to listen ...
... 7 David B. Snow Jr., chairman and chief executive ... is scheduled to address the 27th Annual JPMorgan Healthcare Conference ... the Westin St. Francis Hotel, San Francisco, will begin at ... scheduled to attend are Richard J. Rubino, chief financial officer, ...
... mistakes shownOAKBROOK TERRACE, Ill., Jan. 7 Even though ... new study published in the January 2009 issue of ... Safety shows that nurses often are not included ... play such a hands-on role at the bedside of ...
... Music Superstar Signs on with alli to Aid ... alli announced today the signing of music superstar ... weight loss aid. Its sensible and easy-to-use ... forward to sharing her experiences and encouragement with ...
... ADDY and Telly Awards Honor CyberKnife Print and ... (Nasdaq: ARAY ), a global leader ... company has received three prestigious awards for its ... System.Accuray and RBG Marketing, who created the ads, ...
Cached Medicine News:Health News:ValueOptions(R) Enters Agreement with CareIntegra to Provide Integrated Health Services 2Health News:Kendle to Present at 27th Annual J.P. Morgan Healthcare Conference 2Health News:Medco CEO to Present at the 27th Annual JPMorgan Healthcare Conference 2Health News:Study Finds Failure to Include Nurses in Process of Admitting Errors to Patients, Families 2Health News:Study Finds Failure to Include Nurses in Process of Admitting Errors to Patients, Families 3Health News:Wynonna Judd Reveals Her alli(R), Her Story for Finding a Healthier Lifestyle 2Health News:Wynonna Judd Reveals Her alli(R), Her Story for Finding a Healthier Lifestyle 3Health News:Accuray Receives Prestigious Awards for 2008 Advertising Campaign 2Health News:Accuray Receives Prestigious Awards for 2008 Advertising Campaign 3Health News:Accuray Receives Prestigious Awards for 2008 Advertising Campaign 4
(Date:9/2/2015)... 2015  The report on breast cancer therapeutics: pipeline ... drugs on the basis of the molecules which are ... inner lining of milk ducts or lobules responsible for ... tumor that can spread to other cells present in ... lobules is referred as lobular carcinoma, while the other ...
(Date:9/2/2015)... , Sept. 2, 2015 About ... an X-linked disease, which generally affects the male ... and weakness. The disease is caused due to ... the lack of production of dystrophin (a protein ... The lack of dystrophin weakens muscle function, causes ...
(Date:9/2/2015)... 2015 About Chronic Lymphocytic Leukemia ... by increased production of lymphocytes. It has been observed ... can spread to other parts of the body. This ... the slow buildup of the cancerous cells. During the ... spleen, liver, and lymph nodes. The course of the ...
Breaking Medicine Technology:Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 3Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 2Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 3
...  24, 2011 Sanofi (EURONEXT: SAN and NYSE: ...  of its once-daily GLP-1 receptor agonist Lyxumia® (lixisenatide) that ... demonstrates positive results in type 2 diabetes patients not ... These data are being presented or published at the ...
... 2011 Daniels Sharpsmart Inc., the world,s largest provider ... Bronx medical waste facility from Stericycle making Daniels the ... (Photo: http://photos.prnewswire.com/prnh/20110624/DC25808 ) ... in the United States, significantly expands Daniels, capabilities throughout ...
Cached Medicine Technology:Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions 2Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions 3Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions 4Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions 5Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions 6Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions 7Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions 8Daniels Jumps to No. 2 in Medical Waste Disposal Industry 2
For the screening and detection by indirect immunofluorescence (IF) of primarily anti-myelin associated glycoproteins (anti-MAG) and other glycolipid autoantibodies in human serum....
Triturus® is an open and completely automated ELISA immunoassay analyzer which can perform a variety of different tests on a series of samples and process several batches simultaneously....
... assay that quantifies the likelihood of breast ... early stage breast cancer. In addition to ... assesses the benefit from certain types of ... paraffin-embedded tumor tissue analyzes the expression ...
... The Her-2/neu protein is a 185 ... activity. Approximately 20-30% cases of breast cancer ... in tumor cells. Since the introduction of ... cancer, the clinical testing of Her-2/neu in ...
Medicine Products: